Stay updated with breaking news from Nasdaq Nrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Rating) insider Gwenn Hansen sold 1,136 shares of the business’s stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $9.88, for a total value of $11,223.68. Following the completion of the transaction, the insider now owns 26,632 shares of […]
Los Angeles Capital Management LLC lifted its holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Rating) by 57.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 106,479 shares of the company’s stock after purchasing an additional 38,824 shares during the quarter. Los Angeles […]
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Rating) insider Gwenn Hansen sold 1,136 shares of the stock in a transaction dated Monday, May 1st. The stock was sold at an average price of $9.88, for a total transaction of $11,223.68. Following the transaction, the insider now owns 26,632 shares of the company’s stock, valued at approximately […]
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Rating)’s stock price was down 3.2% during trading on Tuesday . The company traded as low as $12.71 and last traded at $12.85. Approximately 34,391 shares were traded during trading, a decline of 90% from the average daily volume of 356,643 shares. The stock had previously closed at $13.28. […]
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Rating) have received an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1-year […]